Femme Homme
- | Pays :
- Greece
- | Organes : -
- | Spécialités : -
Extrait
Topotecan and gemcitabine are drugs globally registered for recurrent ovarian carcinoma. This trial will determine the maximum tolerated dose and the efficacy of this combination administered weekly in patients with platinum -resistant ovarian cancer.
Critère d'inclusion
- Ovarian Cancer